Correlation Between BANK CENTRAL and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BANK CENTRAL and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BANK CENTRAL and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BANK CENTRAL ASIA and BioNTech SE, you can compare the effects of market volatilities on BANK CENTRAL and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BANK CENTRAL with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of BANK CENTRAL and BioNTech.

Diversification Opportunities for BANK CENTRAL and BioNTech

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between BANK and BioNTech is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding BANK CENTRAL ASIA and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and BANK CENTRAL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BANK CENTRAL ASIA are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of BANK CENTRAL i.e., BANK CENTRAL and BioNTech go up and down completely randomly.

Pair Corralation between BANK CENTRAL and BioNTech

Assuming the 90 days trading horizon BANK CENTRAL ASIA is expected to under-perform the BioNTech. But the stock apears to be less risky and, when comparing its historical volatility, BANK CENTRAL ASIA is 1.73 times less risky than BioNTech. The stock trades about -0.07 of its potential returns per unit of risk. The BioNTech SE is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  11,000  in BioNTech SE on October 8, 2024 and sell it today you would earn a total of  460.00  from holding BioNTech SE or generate 4.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BANK CENTRAL ASIA  vs.  BioNTech SE

 Performance 
       Timeline  
BANK CENTRAL ASIA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BANK CENTRAL ASIA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
BioNTech SE 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, BioNTech may actually be approaching a critical reversion point that can send shares even higher in February 2025.

BANK CENTRAL and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BANK CENTRAL and BioNTech

The main advantage of trading using opposite BANK CENTRAL and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BANK CENTRAL position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind BANK CENTRAL ASIA and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes